Atea Pharmaceuticals Inc (NASDAQ: AVIR) started the day on Wednesday, with a price increase of 4.38% at $3.1, before settling in for the price of $2.97 at the close. Taking a more long-term approach, AVIR posted a 52-week range of $2.45-$4.02.
It was noted that the giant of the Healthcare sector posted annual sales growth of -63.72% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -63.72%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 18.25%. This publicly-traded company’s shares outstanding now amounts to $81.14 million, simultaneously with a float of $64.31 million. The organization now has a market capitalization sitting at $246.01 million. At the time of writing, stock’s 50-day Moving Average stood at $3.27, while the 200-day Moving Average is $3.17.
Atea Pharmaceuticals Inc (AVIR) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Atea Pharmaceuticals Inc’s current insider ownership accounts for 18.96%, in contrast to 63.45% institutional ownership. According to the most recent insider trade that took place on Dec 10 ’24, this organization’s Director sold 359,606 shares at the rate of 2.85, making the entire transaction reach 1,023,475 in total value, affecting insider ownership by 451,897.
Atea Pharmaceuticals Inc (AVIR) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
Atea Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 18.25% and is forecasted to reach -1.65 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 13.82% through the next 5 years, which can be compared against the -63.72% growth it accomplished over the previous five years trading on the market.
Atea Pharmaceuticals Inc (NASDAQ: AVIR) Trading Performance Indicators
Let’s observe the current performance indicators for Atea Pharmaceuticals Inc (AVIR). It’s Quick Ratio in the last reported quarter now stands at 19.17.
In the same vein, AVIR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.61, a figure that is expected to reach -0.41 in the next quarter, and analysts are predicting that it will be -1.65 at the market close of one year from today.
Technical Analysis of Atea Pharmaceuticals Inc (AVIR)
If we take a close look at the recent performances of Atea Pharmaceuticals Inc (NASDAQ: AVIR), its last 5-days Average volume was 0.82 million that shows progress from its year to date volume of 0.38 million. During the previous 9 days, stock’s Stochastic %D was recorded 78.59% While, its Average True Range was 62.93.
Raw Stochastic average of Atea Pharmaceuticals Inc (AVIR) in the period of the previous 100 days is set at 35.66%, which indicates a major fall in contrast to 100.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.11 that was lower than 0.14 volatility it exhibited in the past 100-days period.
